ArticleArchives of microbiology2026
Xylooligosaccharide in combination with Lactobacillus rhamnosus ameliorates disturbed circadian rhythm and associated neurological internal desynchronization by maintaining homeostasis of neuroactive molecules and gut microbiome.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disturbances in circadian rhythm and internal desynchronization are increasingly associated with various neurological health conditions, highlighting the need for effective therapeutic interventions. In the present study, we hypothesized a strong correlation between Prebiotics-Gut Microbiota-Circadian Rhythm, capable of influencing host neurochemical and physiological homeostasis. The effects of a synbiotic formulation comprising a well-characterized xylooligosaccharide (XOS) and Lactobacillus rhamnosus on circadian rhythm regulation in a Caco-2 cell model were investigated. The synbiotic treatment, effectively ameliorated disturbed circadian rhythm in Caco-2 cells and improved neurological internal synchronization through the modulation of neuroactive molecules, which was confirmed by the RT-PCR gene expression studies and transcriptome analysis. Among 73 circadian rhythm regulatory genes, 34 genes showed recovery toward normal expression levels, including PER1, PER2, CRY1, CRY2, and DBP. Furthermore, transcriptomic profiling revealed a significant recovery of neurotransmitter-related genes (DDC, TPH1, COMT, MAOA), suggesting a mechanistic link between circadian recovery and neurochemical pathways. Analysis of gut microbiota-derived metabolites demonstrated increased levels of serotonin, dopamine, and GABA in the treated Caco-2 cells, supporting the role of microbial metabolites in modulating host circadian rhythm. The findings indicate that XOS plays a central role not only as a prebiotic but also as a functional carbohydrate capable of influencing host chronobiology through gut microbiota interactions. These findings provide valuable insights into the complex interplay between circadian rhythm gene regulation and microbial metabolites. The results advance our understanding of the structure–function relationship of XOS in health applications and highlight its promise in developing targeted interventions for circadian rhythm-associated disorders.
Indexed as
Identifiers
41711893What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.